Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vmf 500mg/0.2mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Psychotropics India Ltd

Salt Composition

Metformin (500mg) + Voglibose (0.2mg)

Overview Vmf 500mg/0.2mg Tablet SR

Diabex 500 mg/0.2 mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adult patients. It effectively regulates blood glucose levels in individuals with this condition. Diabex 500 mg/0.2 mg Extended-Release Tablets should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage will be determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with well-controlled blood sugar, as discontinuation without medical consultation could lead to elevated glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive diabetes management plan, incorporating a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications are essential for diabetes control. Potential side effects include nausea, altered taste perception, appetite changes, gas, abdominal discomfort, diarrhea, and skin rashes. These are generally transient and resolve spontaneously; however, persistent or concerning side effects warrant medical attention. Your doctor can provide strategies for managing or treating troublesome side effects. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment, as it may be unsuitable. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to monitor blood cell counts and liver function.

Primary Ingredients of Vmf 500mg/0.2mg Tablet SR

No text provided. Please provide the text you want me to rephrase.

Uses of Vmf 500mg/0.2mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of Vmf 500mg/0.2mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Vmf 500 mg/0.2 mg sustained-release tablet should be taken with a meal.

Common Side effects of Vmf 500mg/0.2mg Tablet SR:

  • Flatulence
  • Diarrhea
  • Abdominal pain
  • Vomiting
  • Decreased appetite

How to use Vmf 500mg/0.2mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Vmf 500 mg/0.2 mg sustained-release tablet should be administered with a meal.

How Vmf 500mg/0.2mg Tablet SR works:

Each Vmf 500 mg/0.2 mg sustained-release tablet contains a dual antidiabetic medication formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Vmf 500 mg/0.2 mg Tablet SR poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Vmf 500 mg/0.2 mg tablet might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Vmf 500 mg/0.2 mg tablets are likely unsafe for breastfeeding mothers. Scant human evidence indicates potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingSAFE

The extended-release Vmf 500 mg/0.2 mg tablet generally has no impact on driving ability. Nevertheless, patients should be aware of the potential for low blood sugar (hypoglycemia) if taken concurrently with other diabetes medications like sulfonylureas, insulin, or repaglinide.

KidneyKidneyCAUTION

Patients with kidney impairment should use Vmf 500 mg/0.2 mg sustained-release tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Vmf 500 mg/0.2 mg sustained-release tablets. Physician consultation is recommended. Regular monitoring of renal function is advised during treatment.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the use of Vmf 500 mg/0.2 mg sustained-release tablets in individuals with hepatic impairment. Seek medical advice.

What if you forget to take Vmf 500mg/0.2mg Tablet SR :

Should you forget to take your Vmf 500 mg/0.2 mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Vmf 500mg/0.2mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Vmf 500mg/0.2mg Tablet SR

.
Vmf 500mg/0.2mg Tablet SR
53
MRP 65
18% off